GLUE SCHEDULE 13G: SEC filing

Vestal Point Capital, LP

Filed with the SEC on · accession 0000902664-26-003506

GLUE filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. Vestal Point Capital, LP filed a Schedule 13G joint acquisition statement regarding its beneficial ownership position in Monte Rosa Therapeutics, Inc. (GLUE). The stock moved -2.1% by the first close after the filing.

Summary of the filing

Vestal Point Capital, LP filed a Schedule 13G joint acquisition statement regarding its beneficial ownership position in Monte Rosa Therapeutics, Inc. (GLUE). The filing is a passive ownership disclosure with no stated intent to influence control of the company.

Key details

Reporting beneficial owner (filer)Vestal Point Capital, LP
Issuer of securities subject to the schedule 13g filingMonte Rosa Therapeutics, Inc.
Chief investment officer and managing partner, vestal point capital, llcRyan Wilder

How GLUE stock reacted

Close before

$15.84

Aug 13, 2026

First close after

-2.15%

$15.50

5 trading days

-6.69%

$14.78

Since filing

-32.86%

$10.63

✦ Ask GOAX AI about this filing — what it means for GLUE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GLUE?

Click here

Frequently asked questions

What did GLUE file with the SEC on Aug 14, 2026?

GLUE filed a SCHEDULE 13G (SEC filing). Vestal Point Capital, LP filed a Schedule 13G joint acquisition statement regarding its beneficial ownership position in Monte Rosa Therapeutics, Inc. (GLUE). The filing is a passive ownership disclosure with no stated intent to influence control of the company.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did GLUE stock react to this filing?

GLUE closed at $15.84 before the filing and $15.50 on Aug 14, 2026 (-2.15%). Five trading days later: $14.78 (-6.69%).

Other GLUE SEC filings

Get alerts when GLUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days